Liom Non-invasive Continuous Glucose Monitor "Clinical Demo" (niCGM)

Inclusion Criteria: * Male or female trial participant with clinically diagnosed type 1 or type 2 diabetes for at least 1 year. * Age between 18 and 65 years, both inclusive. * Treated with insulin and/or oral antidiabetic drugs (OADs; type 2 only), multiple dosing insulin therapy (MDI), continuous subcutaneous insulin infusion (CSII) or a hybrid closed loop system. Exclusion Criteria: * Known or suspected hypersensitivity to any of the components of the Liom Clinical Demo 2.0. * Trial participant with any injury, infection, atypical skin condition (e.g., hyperkeratosis, hyperpigmentation) of or tattoo on the wrists. * Presence or history of a cardiovascular disease including stable and unstable angina pectoris, myocardial infarction, transient ischaemic attack, stroke, cardiac decompensation, clinically significant arrhythmias or clinically significant conduction disorders.